Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Other Non-Current Liabilities (2020 - 2021)

Protagonist Therapeutics' Other Non-Current Liabilities history spans 2 years, with the latest figure at $121000.0 for Q3 2021.

  • For Q3 2021, Other Non-Current Liabilities fell 28.82% year-over-year to $121000.0; the TTM value through Sep 2021 reached $121000.0, down 28.82%, while the annual FY2020 figure was $121000.0, N/A changed from the prior year.
  • Other Non-Current Liabilities for Q3 2021 was $121000.0 at Protagonist Therapeutics, roughly flat from $121000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $170000.0 in Q3 2020 and bottomed at $92000.0 in Q2 2020.